Substance P-induced trafficking of beta-arrestins. The role of beta-arrestins in endocytosis of the neurokinin-1 receptor
about
Interaction with beta-arrestin determines the difference in internalization behavor between beta1- and beta2-adrenergic receptorsHomologous and heterologous uncoupling of muscarinic M(3) and alpha(1B) adrenoceptors to Galpha(q/11) in SH-SY5Y human neuroblastoma cellsEndothelin-converting enzyme-1 regulates trafficking and signalling of the neurokinin 1 receptor in endosomes of myenteric neuronesSingle Molecule Imaging Deciphers the Relation between Mobility and Signaling of a Prototypical G Protein-coupled Receptor in Living Cells.Exploring the dynamics of regulation of G protein-coupled receptors using green fluorescent proteinEndothelin-converting enzyme 1 and β-arrestins exert spatiotemporal control of substance P-induced inflammatory signals.Heterologous regulation of trafficking and signaling of G protein-coupled receptors: beta-arrestin-dependent interactions between neurokinin receptors.Rab5a and rab11a mediate agonist-induced trafficking of protease-activated receptor 2.Methamphetamine induces striatal neurokinin-1 receptor endocytosis primarily in somatostatin/NPY/NOS interneurons and the role of dopamine receptors in miceTachykinins and tachykinin receptors in bone.Protein phosphatase 2A mediates resensitization of the neurokinin 1 receptor.Endothelin-converting enzyme 1 degrades neuropeptides in endosomes to control receptor recycling.Protein Kinase D and Gβγ Subunits Mediate Agonist-evoked Translocation of Protease-activated Receptor-2 from the Golgi Apparatus to the Plasma Membrane.Divergent β-arrestin-dependent signaling events are dependent upon sequences within G-protein-coupled receptor C terminiThe proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta -arrestin-dependent scaffolding complexEndosomal endothelin-converting enzyme-1: a regulator of beta-arrestin-dependent ERK signaling.Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease.TACR3 mutations disrupt NK3R function through distinct mechanisms in GnRH-deficient patients.Arresting inflammation: contributions of plasma membrane and endosomal signalling to neuropeptide-driven inflammatory disease.Selective regulation of endogenous G protein-coupled receptors by arrestins in HEK293 cells.Neuropeptide substance P and the immune response.Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief.Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis.Ubiquitin-dependent down-regulation of the neurokinin-1 receptor.Constitutive ERK1/2 activation by a chimeric neurokinin 1 receptor-beta-arrestin1 fusion protein. Probing the composition and function of the G protein-coupled receptor "signalsome".Recycling and resensitization of the neurokinin 1 receptor. Influence of agonist concentration and Rab GTPases.Methods of measuring internalization of G protein-coupled receptors.Protein kinase C-mediated desensitization of the neurokinin 1 receptor.Activation of protein kinase D by signaling through the alpha subunit of the heterotrimeric G protein G(q).Activation of protein kinase D by signaling through Rho and the alpha subunit of the heterotrimeric G protein G13.Deletion of neutral endopeptidase exacerbates intestinal inflammation induced by Clostridium difficile toxin A.Virokinin, a bioactive peptide of the tachykinin family, is released from the fusion protein of bovine respiratory syncytial virus.Agonist-independent desensitization and internalization of the human platelet-activating factor receptor by coumermycin-gyrase B-induced dimerization.Termination of protease-activated receptor-1 signaling by beta-arrestins is independent of receptor phosphorylation.Molecular identification and characterization of three isoforms of tachykinin NK(1)-like receptors in the cane toad Bufo marinus.Identification of single-nucleotide polymorphisms of the human neurokinin 1 receptor gene and pharmacological characterization of a Y192H variant.Dynamin and Rab5a-dependent trafficking and signaling of the neurokinin 1 receptor.Activation of neurokinin 3 receptor increases Na(v)1.9 current in enteric neurons.NK-1 receptor desensitization and neutral endopeptidase terminate SP-induced pancreatic plasma extravasation.Development of a BRET2 screening assay using beta-arrestin 2 mutants.
P2860
Q28138963-DE3D9AE3-8B5A-4950-9237-60E0A15361B8Q28356830-43E7D4FC-B034-4235-8B3C-AE97BEBA6620Q28579599-D031AC05-70BC-49BE-808E-D6EE6508B136Q30677207-C7C7D11F-D6EA-41B7-9C18-FFCF192C2F59Q33749457-50DEF7E4-ED88-4D09-9B55-2341A70BA8C1Q33931244-17766037-982D-47C6-9C75-7A247ECBD1ADQ34017695-B66281B6-1DDE-4E68-9253-DF6A14B9B9CFQ34172035-BAF88D82-59C4-48EB-A136-7793C5A0F15DQ34388424-DBDFE400-0DDA-40A9-9E00-762BE910C83FQ34803993-7CB04512-D619-4A64-B53B-E84F3759C968Q35322050-CCC3EA26-EBDE-430F-A79E-A02D5E9BDE5EQ35880284-DE069345-C804-4898-BF9D-B87A3EB1A888Q35974569-74BB8EEC-CF05-4BD7-B221-21FBEED22836Q36579520-BACF9C31-F869-485D-A772-55A81014FC0AQ37273521-AF027305-58C1-4F0B-875C-6BB039313325Q37372302-01BB4AE8-CC45-460A-9656-1418C1203F3EQ37593097-CF406C4F-E476-4BFB-9444-CF4D74939B48Q37657090-F3D88CC9-C190-400C-8A2C-498E69996092Q38077221-9B9F1D0D-8FFF-4A7C-9C55-C367778D9874Q38313021-9F1F649E-1C10-4E4F-BA61-D15C57902B57Q38868323-A53E5025-FCDC-47BD-90EB-26A105FAF8B0Q39154920-B4DC0BB5-6198-454A-91A4-AB42ADC19F23Q40085168-87F3468A-A37C-4471-B38A-C1F481A0747EQ40254275-6456D22F-96C1-483C-8FD2-92E7517A67E2Q40284486-8A106E29-38FA-4C6B-89C9-7C61339308DDQ40558816-4DE224A4-0A1E-4DAF-A96F-0AE5C5889374Q40561392-907FFFD0-185F-4723-8516-ACAE8978EE3CQ40814998-EE1BE73D-A96F-4DB0-BD2B-89B8169A65A6Q41714408-F8C3F2ED-7197-4E3A-B1F4-8721848EC856Q42508695-F60FFCA2-56AC-48AB-AE53-706944A8FECDQ43669442-7EFA105C-1FBA-4D95-9C9D-51432DE604B6Q44354620-16BE7704-A72B-4E22-9D6A-FEA2567BE78CQ44447205-08DE1D92-F5B0-4D50-A50F-E995AFF1C274Q44709098-AA1E633A-54CE-4667-8E71-6E2420FE8C82Q44904450-BB9670F5-C6E4-4F17-A667-8FD965B2C43AQ45081687-4EA308E5-64A5-484D-B5E1-4A5B0D1B65CDQ46062295-E75382D7-6AAF-454A-B31C-68338AC07CF1Q46127921-F391DCA5-705B-4A47-9245-7F6BA08F13D3Q46504409-C215CA17-AE00-4FDA-814F-1A6FB3E5A6C9Q47360713-A86A701B-263B-4E7F-96FB-6A7704A27AA3
P2860
Substance P-induced trafficking of beta-arrestins. The role of beta-arrestins in endocytosis of the neurokinin-1 receptor
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Substance P-induced traffickin ...... s of the neurokinin-1 receptor
@ast
Substance P-induced traffickin ...... s of the neurokinin-1 receptor
@en
Substance P-induced traffickin ...... s of the neurokinin-1 receptor
@nl
type
label
Substance P-induced traffickin ...... s of the neurokinin-1 receptor
@ast
Substance P-induced traffickin ...... s of the neurokinin-1 receptor
@en
Substance P-induced traffickin ...... s of the neurokinin-1 receptor
@nl
prefLabel
Substance P-induced traffickin ...... s of the neurokinin-1 receptor
@ast
Substance P-induced traffickin ...... s of the neurokinin-1 receptor
@en
Substance P-induced traffickin ...... s of the neurokinin-1 receptor
@nl
P2093
P356
P1476
Substance P-induced traffickin ...... s of the neurokinin-1 receptor
@en
P2093
K McConalogue
N W Bunnett
P304
P356
10.1074/JBC.274.23.16257
P407
P577
1999-06-04T00:00:00Z